Development of [<sup>124/125</sup>I]IAZA as a New Proteinopathy Imaging Agent for Alzheimer’s Disease
Radioiodinated imaging agents for Aβ amyloid plaque imaging in Alzheimer’s disease (AD) patients have not been actively pursued. Our previous studies employed the “diaza” derivatives [<sup>11</sup>C]TAZA and [<sup>18</sup>F]flotaza in order to develop successful positron emis...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/28/2/865 |